Barras D - Search Results

1

The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner.

Heulot M, Chevalier N, Puyal J, Margue C, Michel S, Kreis S, Kulms D, Barras D, Nahimana A, Widmann C. Heulot M, et al. Among authors: barras d. Oncotarget. 2016 Sep 27;7(39):64342-64359. doi: 10.18632/oncotarget.11841. Oncotarget. 2016. PMID: 27602963 Free PMC article.

2

Promises of apoptosis-inducing peptides in cancer therapeutics.

Barras D, Widmann C. Barras D, et al. Curr Pharm Biotechnol. 2011 Aug;12(8):1153-65. doi: 10.2174/138920111796117337. Curr Pharm Biotechnol. 2011. PMID: 21470140 Review.

3

Inhibition of cell migration and invasion mediated by the TAT-RasGAP317-326 peptide requires the DLC1 tumor suppressor.

Barras D, Lorusso G, Rüegg C, Widmann C. Barras D, et al. Oncogene. 2014 Oct 30;33(44):5163-72. doi: 10.1038/onc.2013.465. Epub 2013 Nov 11. Oncogene. 2014. PMID: 24213569 Free article.

4

GAP-independent functions of DLC1 in metastasis.

Barras D, Widmann C. Barras D, et al. Cancer Metastasis Rev. 2014 Mar;33(1):87-100. doi: 10.1007/s10555-013-9458-0. Cancer Metastasis Rev. 2014. PMID: 24338004 Free article. Review.

5

Fragment N2, a caspase-3-generated RasGAP fragment, inhibits breast cancer metastatic progression.

Barras D, Lorusso G, Lhermitte B, Viertl D, Rüegg C, Widmann C. Barras D, et al. Int J Cancer. 2014 Jul 1;135(1):242-7. doi: 10.1002/ijc.28674. Epub 2014 Mar 4. Int J Cancer. 2014. PMID: 24347041 Free article.

6

A WXW motif is required for the anticancer activity of the TAT-RasGAP317-326 peptide.

Barras D, Chevalier N, Zoete V, Dempsey R, Lapouge K, Olayioye MA, Michielin O, Widmann C. Barras D, et al. J Biol Chem. 2014 Aug 22;289(34):23701-11. doi: 10.1074/jbc.M114.576272. Epub 2014 Jul 9. J Biol Chem. 2014. PMID: 25008324 Free PMC article.

7

Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.

Flahaut M, Jauquier N, Chevalier N, Nardou K, Balmas Bourloud K, Joseph JM, Barras D, Widmann C, Gross N, Renella R, Mühlethaler-Mottet A. Flahaut M, et al. Among authors: barras d. BMC Cancer. 2016 Oct 10;16(1):781. doi: 10.1186/s12885-016-2820-1. BMC Cancer. 2016. PMID: 27724856 Free PMC article.

8

The Anticancer Peptide TAT-RasGAP_317-326 Exerts Broad Antimicrobial Activity.

Heulot M, Jacquier N, Aeby S, Le Roy D, Roger T, Trofimenko E, Barras D, Greub G, Widmann C. Heulot M, et al. Among authors: barras d. Front Microbiol. 2017 Jun 7;8:994. doi: 10.3389/fmicb.2017.00994. eCollection 2017. Front Microbiol. 2017. PMID: 28638371 Free PMC article.

9

RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.

Gbenedio OM, Bonnans C, Grun D, Wang CY, Hatch AJ, Mahoney MR, Barras D, Matli M, Miao Y, Garcia KC, Tejpar S, Delorenzi M, Venook AP, Nixon AB, Warren RS, Roose JP, Depeille P. Gbenedio OM, et al. Among authors: barras d. JCI Insight. 2019 Jun 25;5(15):e127552. doi: 10.1172/jci.insight.127552. JCI Insight. 2019. PMID: 31237864 Free PMC article.

10

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.

Lan Q, Peyvandi S, Duffey N, Huang YT, Barras D, Held W, Richard F, Delorenzi M, Sotiriou C, Desmedt C, Lorusso G, Rüegg C. Lan Q, et al. Among authors: barras d. Oncogene. 2019 Apr;38(15):2814-2829. doi: 10.1038/s41388-018-0624-2. Epub 2018 Dec 13. Oncogene. 2019. PMID: 30546090 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page